eF-site ID 4fx3-ABCD PDB Code 4fx3 Chain A, B, C, D click to enlarge Title Crystal Structure of the CDK2/Cyclin A complex with oxindole inhibitor Classification transferase/transferase inhibitor Compound Cyclin-dependent kinase 2 Source Homo sapiens (Human) (CCNA2_HUMAN) Sequence A:  MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA LAHPFFQDVTKPVPHLRL B:  PDYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAILV DWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQL VGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRME HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMF LGELSLIDADPYLKYLPSVIAGAAFHLALYTVTGQSWPES LIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYKN SKYHGVSLLNPPETLNL C:  MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA LAHPFFQDVTKPVPHLRL D:  VPDYHEDIHTYLREMEVKCKPKVGYMKKQPDITNSMRAIL VDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSVLRGKLQ LVGTAAMLLASKFEEIYPPEVAEFVYITDDTYTKKQVLRM EHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAM FLGELSLIDADPYLKYLPSVIAGAAFHLALYTVTGQSWPE SLIRKTGYTLESLKPCLMDLHQTYLKAPQHAQQSIREKYK NSKYHGVSLLNPPETLNL Description Functional site 1) chain A residue 10 type sequence I description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 2) chain A residue 31 type sequence A description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 3) chain A residue 33 type sequence K description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 4) chain A residue 64 type sequence V description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 5) chain A residue 80 type sequence F description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 6) chain A residue 81 type sequence E description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 7) chain A residue 82 type sequence F description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 8) chain A residue 83 type sequence L description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 9) chain A residue 84 type sequence H description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 10) chain A residue 85 type sequence Q description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 11) chain A residue 86 type sequence D description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 12) chain A residue 89 type sequence K description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 13) chain A residue 134 type sequence L description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 14) chain A residue 145 type sequence D description BINDING SITE FOR RESIDUE 60K A 301 source : AC1 15) chain A residue 56 type sequence K description BINDING SITE FOR RESIDUE DTT A 302 source : AC2 16) chain A residue 66 type sequence L description BINDING SITE FOR RESIDUE DTT A 302 source : AC2 17) chain A residue 68 type sequence D description BINDING SITE FOR RESIDUE DTT A 302 source : AC2 18) chain A residue 69 type sequence V description BINDING SITE FOR RESIDUE DTT A 302 source : AC2 19) chain B residue 213 type sequence I description BINDING SITE FOR RESIDUE DTT B 501 source : AC3 20) chain B residue 214 type sequence L description BINDING SITE FOR RESIDUE DTT B 501 source : AC3 21) chain B residue 253 type sequence L description BINDING SITE FOR RESIDUE DTT B 501 source : AC3 22) chain C residue 10 type sequence I description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 23) chain C residue 31 type sequence A description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 24) chain C residue 33 type sequence K description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 25) chain C residue 80 type sequence F description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 26) chain C residue 81 type sequence E description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 27) chain C residue 82 type sequence F description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 28) chain C residue 83 type sequence L description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 29) chain C residue 84 type sequence H description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 30) chain C residue 85 type sequence Q description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 31) chain C residue 86 type sequence D description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 32) chain C residue 89 type sequence K description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 33) chain C residue 134 type sequence L description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 34) chain C residue 145 type sequence D description BINDING SITE FOR RESIDUE 60K C 301 source : AC4 35) chain D residue 210 type sequence M description BINDING SITE FOR RESIDUE DTT D 501 source : AC5 36) chain D residue 213 type sequence I description BINDING SITE FOR RESIDUE DTT D 501 source : AC5 37) chain D residue 214 type sequence L description BINDING SITE FOR RESIDUE DTT D 501 source : AC5 38) chain D residue 254 type sequence Q description BINDING SITE FOR RESIDUE DTT D 501 source : AC5 39) chain A residue 160 type MOD_RES sequence T description Phosphothreonine; by CAK and CCRK => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:14597612, ECO:0000269|PubMed:16325401, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:17570665, ECO:0000269|PubMed:20147522, ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:21565702, ECO:0000305|PubMed:28666995 source Swiss-Prot : SWS_FT_FI10 40) chain C residue 160 type MOD_RES sequence T description Phosphothreonine; by CAK and CCRK => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:14597612, ECO:0000269|PubMed:16325401, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:17570665, ECO:0000269|PubMed:20147522, ECO:0000269|PubMed:20360007, ECO:0000269|PubMed:21565702, ECO:0000305|PubMed:28666995 source Swiss-Prot : SWS_FT_FI10 41) chain A residue 10 type BINDING sequence I description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 42) chain C residue 129 type BINDING sequence K description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 43) chain A residue 33 type BINDING sequence K description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 44) chain A residue 81 type BINDING sequence E description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 45) chain A residue 86 type BINDING sequence D description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 46) chain A residue 129 type BINDING sequence K description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 47) chain C residue 10 type BINDING sequence I description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 48) chain C residue 33 type BINDING sequence K description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 49) chain C residue 81 type BINDING sequence E description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 50) chain C residue 86 type BINDING sequence D description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI2 51) chain A residue 1 type MOD_RES sequence M description N-acetylmethionine => ECO:0007744|PubMed:22814378 source Swiss-Prot : SWS_FT_FI5 52) chain C residue 1 type MOD_RES sequence M description N-acetylmethionine => ECO:0007744|PubMed:22814378 source Swiss-Prot : SWS_FT_FI5 53) chain A residue 127 type ACT_SITE sequence D description Proton acceptor source Swiss-Prot : SWS_FT_FI1 54) chain C residue 127 type ACT_SITE sequence D description Proton acceptor source Swiss-Prot : SWS_FT_FI1 55) chain A residue 132 type BINDING sequence N description BINDING => ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI3 56) chain A residue 145 type BINDING sequence D description BINDING => ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI3 57) chain C residue 132 type BINDING sequence N description BINDING => ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI3 58) chain C residue 145 type BINDING sequence D description BINDING => ECO:0000269|PubMed:21565702 source Swiss-Prot : SWS_FT_FI3 59) chain A residue 9 type SITE sequence K description CDK7 binding source Swiss-Prot : SWS_FT_FI4 60) chain A residue 88 type SITE sequence K description CDK7 binding source Swiss-Prot : SWS_FT_FI4 61) chain A residue 166 type SITE sequence L description CDK7 binding source Swiss-Prot : SWS_FT_FI4 62) chain C residue 9 type SITE sequence K description CDK7 binding source Swiss-Prot : SWS_FT_FI4 63) chain C residue 88 type SITE sequence K description CDK7 binding source Swiss-Prot : SWS_FT_FI4 64) chain C residue 166 type SITE sequence L description CDK7 binding source Swiss-Prot : SWS_FT_FI4 65) chain A residue 6 type MOD_RES sequence K description N6-acetyllysine => ECO:0007744|PubMed:19608861 source Swiss-Prot : SWS_FT_FI6 66) chain C residue 6 type MOD_RES sequence K description N6-acetyllysine => ECO:0007744|PubMed:19608861 source Swiss-Prot : SWS_FT_FI6 67) chain A residue 14 type MOD_RES sequence T description Phosphothreonine => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507 source Swiss-Prot : SWS_FT_FI7 68) chain C residue 14 type MOD_RES sequence T description Phosphothreonine => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507 source Swiss-Prot : SWS_FT_FI7 69) chain A residue 15 type MOD_RES sequence Y description Phosphotyrosine; by WEE1 => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507, ECO:0007744|PubMed:19690332 source Swiss-Prot : SWS_FT_FI8 70) chain C residue 15 type MOD_RES sequence Y description Phosphotyrosine; by WEE1 => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507, ECO:0007744|PubMed:19690332 source Swiss-Prot : SWS_FT_FI8 71) chain A residue 19 type MOD_RES sequence Y description Phosphotyrosine => ECO:0007744|PubMed:19369195 source Swiss-Prot : SWS_FT_FI9 72) chain C residue 19 type MOD_RES sequence Y description Phosphotyrosine => ECO:0007744|PubMed:19369195 source Swiss-Prot : SWS_FT_FI9 73) chain B residue 211-242 type prosite sequence RAILVDWLVEVGEEYKLQNETLHLAVNYIDRF description CYCLINS Cyclins signature. RaiLvdWLvevgeeykLqnetLhlAVnYIDRF source prosite : PS00292 74) chain A residue 10-33 type prosite sequence IGEGTYGVVYKARNKLTGEVVALK description PROTEIN_KINASE_ATP Protein kinases ATP-binding region signature. IGEGTYGVVYkArnkltgev..........VALK source prosite : PS00107 75) chain A residue 123-135 type prosite sequence VLHRDLKPQNLLI description PROTEIN_KINASE_ST Serine/Threonine protein kinases active-site signature. VlHrDLKpqNLLI source prosite : PS00108

Display surface Download Links